14-day Premium Trial Subscription Try For FreeTry Free
FRA:CB5
Delisted

Commerce Bancshares, Inc. Stock Signals

44.20€
+0 (+0%)
At Close: Dec 21, 2023

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 481 days ( 29.84 % )
Last Price 44.20€ 0 %
High/ Low 44.20€ - 44.20€ 0%
Chg 7 Days N/A $44.20 44.20€
Chg 30 Days N/A $44.20 44.20€
Chg 12 mos -27.54 % $61.00 44.20€
Trend - 3 mos -0.0737 % Width: 1.36 %
Trend - 12 mos -32.92 % Width: 37.43 %
Pred. range - 3 mos 44.14€ - 44.74€ -0.145 % - 1.21 %
Pred. range - 12 mos 20.77€ - 28.54€ -53.01 % - -35.42 %
Short MA avg 3 mos Buy Sep 25, 2023 - 64 days
Long MA avg 3 mos Sell Oct 26, 2023 - 41 days
Short/Long MA avg 3 mos Sell Oct 26, 2023 - 41 days
Short MA avg 12 mos Sell Oct 06, 2023 - 55 days
Long MA avg 12 mos Buy Sep 01, 2023 - 80 days
Short/Long MA avg 12 mos Sell Sep 06, 2023 - 77 days
Pivot Short Buy Sep 27, 2023 - 62 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Commerce Bancshares, Inc.

Commerce Bancshares. Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... CB5.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT